The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
reduction in the number of wet nights .
Timeframe: the number of wet nights will be measured and compared at the end of each month for 3 months using a calendar fulfilled by the child and his parents.